治疗复杂尿路感染的口服β-乳:系统性审查和与三甲/硫甲和诺基诺的点对点比较
Ashlan J Kunz Coyne1, Jeannette Bouchard2, Spencer H Durham3
1University of Kentucky, College of Pharmacy, Lexington, Kentucky, USA.
Pharmacotherapy
|February 16, 2026
概括
口服β-乳酸盐在复杂的尿路感染中显示出与诺基诺或trimethoprim/sulfamethoxazole相比的可比性和更好的安全性. 最佳剂量是成功和减少复发的关键,在抗菌药物管理中提供了有价值的替代方案.
科学领域:
- 药理学和传染病的研究
- 抗菌疗法是一种抗菌疗法.
- 临床有效性和安全性
背景情况:
- 诺基诺 (FQs) 和三甲/硫甲 (TMP/SMX) 的耐药性和毒性日益增加,需要针对复杂的尿路感染 (CUTIs) 提供替代方案.
- 口服β-乳糖胺正在被研究为潜在的安全和有效的切口感染的选择.
- 本综述评估了口服β-lactams与FQs和TMP/SMX对于cUTIs,专注于疗效,安全性和药理动力学.
研究的目的:
- 与FQs和TMP/SMX相比,评估口服β-乳酸盐在治疗复杂的尿路感染方面的有效性.
- 在此背景下,评估口服β-乳酸盐的安全性和药理学特征.
- 探索口服β-乳酸胺在抗菌药物管理和以患者为中心的CUTIs护理中的作用.
主要方法:
- 从2000年1月到2025年12月进行系统的PubMed搜索.
- 包括随机试验和观察性队列研究,对口服β-乳酸盐用于cUTIs与FQs或TMP/SMX.
- 综合数据叙述,专注于治疗成功,复发,不良事件和PK考虑.
主要成果:
- 十七项观察性研究表明,当适当剂量使用时,口服β-乳糖胺与FQs和TMP/SMX在治疗尿路感染 (包括细菌性尿路感染) 方面具有可比的有效性.
- 高生物可用性口服β-乳酸取得了>90%的成功率,但低剂量增加了复发.
- 口服β-乳酸的不良事件率较低 (1.3%),相比FQs (2.3%) 和TMP/SMX (5.7%),尽管存在潜在的剂量和敏感性挑战.
结论:
- 选择口服β-乳酸是治疗炎和细菌性尿路感染的FQ或TMP/SMX的有效替代品,特别是在最佳剂量时.
- 这些药物具有良好的安全性,并支持抗菌药物管理.
- 需要进一步的随机试验来确认发现并优化剂量策略.
相关概念视频
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
338
A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
338
Combined Effects of Drugs: Synergism
7.0K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
7.0K
Urinary Tract Infection I: Introduction
766
Urinary tract infections (UTIs) impact various parts of the urinary system, including the kidneys, ureters, bladder, and urethra. These infections are generally bacterial, with Escherichia coli being the most common causative agent, often originating from the gastrointestinal tract. However, other bacteria, such as Staphylococcus saprophyticus, Klebsiella pneumoniae, and Proteus mirabilis, are also known to cause UTIs. The type, location, and underlying complexity of the UTI guide both...
766
Acute Pyelonephritis II: Diagnostic Studies and Management
468
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
468
Urine Studies II: Urine Culture and Sensitivity Test
1.3K
A urine culture and sensitivity test is a diagnostic procedure used to identify urinary tract bacterial infections and determine the most effective antibiotics for treatment. This test is generally preferred when a patient shows manifestations of a urinary tract infection, such as frequent or painful urination, cloudy or foul-smelling urine, or lower abdominal pain.Purpose of the TestThe primary goals of a urine culture and sensitivity test are to:Determine the specific bacteria causing the...
1.3K
Urinary Tract Infection II: Pathophysiology
811
The pathophysiology of urinary tract infections (UTIs) encompasses several progressive stages, beginning with bacterial colonization and culminating in potential systemic complications if untreated. UTIs are primarily initiated by bacteria, such as Escherichia coli, which often originate from the gastrointestinal tract and migrate to the urinary system through the periurethral area. This migration can occur via several routes, including improper hygiene practices, sexual activity, or...
811


